|
|
|
|
Vol. 17, Issue 2, 851-861, February 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Toxicology, University of Mainz, D-55131 Mainz, Germany
Submitted July 7, 2005;
Revised October 31, 2005;
Accepted November 17, 2005
Monitoring Editor: J. Silvio Gutkind
| ABSTRACT |
|---|
|
|
|---|
2 h after exposure) was similar in cells knockout for ATM, PARP, p53, and CSB or defective in DNA-PKcs compared with wild-type cells. The late response however (
4 h), was drastically reduced in DNA-PKcs and Cockayne's syndrome B (CSB)-deficient cells. Similar results were obtained with human cells lacking DNA-PKcs and CSB. Activation of SAPK/JNK by MMS was not affected upon inhibition of base excision repair (BER), indicating base damage itself does not signal to SAPK/JNK. Because SAPK/JNK activation was attenuated in nongrowing cells, DNA replication-dependent processing of lesions, involving DNA-PKcs and CSB, appears to be required. DNA-PKcs coprecipitates with SEK1/MKK4 and SAPK/JNK, supporting a role of DNA-PKcs in SAPK/JNK activation. In this process, Rho GTPases are involved since inhibition of Rho impairs MMS-induced signaling to SAPK/JNK. The data show that sensing of DNA damage by DNA-PKcs and CSB causes a delayed SEK1/MKK4-mediated dual phosphorylation of SAPK/JNK. | INTRODUCTION |
|---|
|
|
|---|
B. The response appears to be biologically highly relevant, because the lack of either one of these transcription factors dramatically impairs cell survival and genomic stability upon genotoxic stress. Thus, cells that are compromised in AP-1-mediated gene expression because of a lack of c-Fos are hypersensitive to a wide spectrum of genotoxic agents (Haas and Kaina, 1995
A central question that still needs to be answered is whether stress kinases are mainly stimulated by receptor activation or DNA damage-related mechanisms. It has been suggested that rapid activation of signaling pathways related to MAP kinase and NF-
B by genotoxins such as UV irradiation and alkylating agents is independent of DNA damage, because 1) their activation was observed in both intact and denucleated cells (Devary et al., 1993
; Wilhelm et al., 1997
), 2) genotoxic agents are able to induce the phosphorylation of growth factor receptors similar to physiological ligands (Coffer et al., 1995
; Huang et al., 1996b
; Knebel et al., 1996
; Gross et al., 1999
; Kitagawa et al., 2002
), and 3) functional inactivation of growth factor receptors impacts on signaling to MAP kinases (Rosette and Karin, 1996
). Based on this, it is believed that various cellular receptors for growth factors and cytokines act as cellular sensors for genotoxins, provoking the rapid activation of MAP kinases and NF-
B that in turn trigger reprogramming of gene expression (Canman and Kastan, 1996
; Rosette and Karin, 1996
). Supporting evidence for the involvement of DNA damage is the finding that the activation of MAP kinases (Nehme et al., 1997
, 1999
) and NF-
B (Bender et al., 1998
) differs between wild-type cells and cell lines containing reduced capacity for the repair of cisplatin and UV-C-induced DNA lesions. It should also be noted that EGF receptor-deficient mutants were similarly effective as wild-type cells in the UV-C-induced activation of AP-1 (Huang et al., 1996a
). Thus, collectively, the contribution of DNA damage-dependent and -independent mechanisms as to the activation of MAP kinase-related signaling pathways is still enigmatic.
In the present study we addressed the question of whether cellular functions related to DNA damage processing and repair may contribute to the activation of SAPK/JNK. The genotoxin model we used was methyl methanesulfonate (MMS), which is a powerful DNA alkylator, genotoxin, and inducer of immediate-early stress responses (van Dam et al., 1995
; Dosch and Kaina, 1996
; Kaina et al., 1997
; Wilhelm et al., 1997
; Kolbus et al., 2000
). We show that MMS provokes a long-lasting dual phosphorylation of SAPK/JNK at Thr183/Tyr185, with an early and a late component. We also show that the late SAPK/JNK phosphorylation requires DNA-PKcs and Cockayne syndrome B (CSB) protein and that it is dependent on Rho GTPases. The essential requirement of the DNA repair proteins DNA-PKcs and CSB for genotoxin-induced SAPK/JNK phosphorylation indicates that DNA damage-related processes are able to act as a trigger for signaling involving SAPK/JNK.
| MATERIALS AND METHODS |
|---|
|
|
|---|
2/SAPK1a protein kinase originates from Kinase Detect ApS (Odense, Denmark).
Cell Culture Conditions
Primary human fibroblasts were grown in F10/Dulbecco (+10% fetal calf serum). All other cell lines used in this study were routinely grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum.
MAP Kinase Activation
Activation of MAP kinases by phosphorylation was measured by Western blot analysis using phospho-specific antibodies that detect the dual phosphorylated (i.e., activated) form of SAPK/JNK (Thr183/Tyr185) and p38 kinase (Thr180/Tyr182). Phospho-specific antibodies were also used for measuring activation of SEK1/MKK4 (Thr261) and Chk1 (Ser345). Cell extracts were prepared by lysing an identical number of cells in boiling SDS sample buffer, as recommended by the manufacturer (New England Biolabs GmbH). Proteins were separated by SDS gel electrophoresis (10% gels) and transferred onto nitrocellulose membrane. After blocking of the membrane (5% dry milk in Tris-buffered saline [TBS]/0.1% Tween, 2 h at RT) phosphorylation status of kinases was analyzed using the corresponding antibody (1:1000, 5% BSA in TBS/0.1% Tween, overnight incubation at 4°C). After washing, blots were incubated with secondary horseradish peroxidase-coupled anti-rabbit-antibody (1:5000, 2 h, RT). Subsequently, phosphorylated kinases were visualized by chemiluminescence using ECL detection reagent (Amersham, Freiburg, Germany).
DNA Replication
To assay the blockade of DNA replication, incorporation of BrdU was quantified by ELISA as described earlier (von Bardeleben et al., 2003
). In brief, treated or nontreated cells were pulse-labeled with BrdU for 30 min. Afterward, incorporated BrdU was quantitated using BrdU-specific antibodies according to the manufacturer's protocol (Roche Diagnostics GmbH, Mannheim, Germany) Relative replication in nontreated control cells was set to 100%.
DNA Strand Break Analysis
To quantify the level of MMS-induced DNA strand breaks, the alkaline comet assay was used as previously described (von Bardeleben et al., 2002
). Exponentially growing cells were treated with MMS for 1 h, carefully rinsed, postincubated at 37°C for the times indicated, and harvested for analysis. Fifty cells were analyzed per measurement as to their olive tail moment (OTM) for calculation of the mean value.
Immunoprecipitation
Cells, 2-5 x 106, were suspended in 1 ml RIPA buffer (10 mM Tris, pH 8.0, 140 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride) and incubated on ice for 10 min to allow cell lysis. Afterward cell debris was removed by centrifugation (10,000 x g, 10 min, 4°C). On addition of protein A agarose beads and the corresponding primary antibody, supernatant was incubated for 6-8 h at 4°C on an overhead shaker to allow binding reactions. After incubation, the agarose bead was pelleted by centrifugation (5 min, 1000 x g, 4°C) and washed three times with RIPA buffer. The pellet was resuspended in SDS sample buffer. After SDS gel electrophoresis, coimmunoprecipitated proteins were identified by Western blot analysis (see above).
In Vitro Kinase Assays
The phosphorylation of DNA-PKcs and SAPK/JNK was analyzed in vitro. On immunoprecipitation of JNK1 from MMS-treated and nontreated cells, phosphorylation of GST-Jun 1/166 (as a control) and purified DNA-PKcs (Promega) was analyzed by immune complex kinase assay as described previously (Gnad et al., 2000
). Briefly, phosphorylation was performed for 20 min at 30°C in 40 µl of JNK reaction buffer (25 mM HEPES, pH 7.6, 20 mM MgCl2, 20 mM
-glycerolphosphate, 0.1 mM sodium orthovanadate, 2 mM dithiothreitol [DTT], 50 µM ATP, and 1 µCi
-32P-ATP) containing either GST-Jun (1 µg) or DNA-PKcs (0.5 µg) as a substrate. To examine whether JNK is a substrate for DNA-PKcs, immunoprecipitated DNA-PKcs or 0.5 µg of purified DNA-PKcs protein was incubated with 1 µg of recombinant HA-JNK2 protein (Kinase Detect ApS) for 20 min at 30°C in 40 µl of DNA-PKcs reaction buffer (50 mM HEPES, 100 mM KCl, 10 mM MgCl2, 0.2 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA, 10 µg/ml sonicated calf thymus DNA, 50 µM ATP, and 1 µCi
-32P-ATP). Products of kinase reactions were separated by SDS-PAGE and visualized by autoradiography of the dried gel.
| RESULTS |
|---|
|
|
|---|
|
inhibitor prunasin (Figure 2B), and the BER incision inhibitor 3-methoxyamine (Figure 2C) did not influence MMS-stimulated phosphorylation of SAPK/JNK. Obviously, neither the DNA lesions themselves nor the process of BER impacts on MMS-induced signaling to SAPK/JNK. Therefore, we addressed secondary DNA lesions induced by MMS as inducer. Critical secondary lesions might be DNA double-strand breaks (DSBs) formed in response to MMS. To assess whether DSBs on their own are sufficient for stimulating dual phosphorylation of SAPK/JNK, we used ionizing radiation (IR) as an inducer. IR did not cause dual phosphorylation of SAPK/JNK, which is in line with other report (Lee et al., 1998
|
MMS-induced DNA Replication Blockade Contributes to SAPK/JNK Phosphorylation
MMS-induced genotoxicity requires DNA replication. Therefore, we checked whether DNA replication is required for MMS-provoked signaling to SAPK/JNK. To this end, we compared MMS-stimulated dual phosphorylation in growing versus nongrowing cells. As shown in Figure 3A, dual phosphorylation of SAPK/JNK but not of p38 kinase, was reduced by
50% in nonreplicating cells. This indicates that replication mediated processes participate in signaling to SAPK/JNK upon MMS treatment. DNA replication inhibition itself might be considered as a trigger. Indeed, inhibition of DNA replication by aphidicolin (Figure 3B) and hydroxyurea (unpublished data) increases phosphorylation of SAPK/JNK and p38 kinase. Simultaneous treatment of cells with MMS and aphidicolin largely potentiated the effect of either of these agents on SAPK/JNK (Figure 3B). The potentiating effect of the combined treatment was less marked for p38 kinase (Figure 3B). On the basis of this finding, we suggest that DNA replication-dependent processes evoked upon MMS treatment are involved in triggering phosphorylation of SAPK/JNK at Thr183/Tyr185.
|
DNA-PKcs Is Essential for Late MMS-triggered Phosphorylation of SAPK/JNK
An attractive hypothesis would be that blockade of DNA replication together with MMS-induced secondary lesions, notably DNA strand breaks, provide the ultimate signal for triggering dual phosphorylation of SAPK/JNK. This hypothesis can be studied best with DNA repair-defective mutants. Therefore, we examined cell lines that are defective in DNA strand break-related signaling and compared them with wild-type cells as to SAPK/JNK phosphorylation by MMS. As analyzed 30-120 min after MMS exposure (designated as "early response"), dual phosphorylation of SAPK/JNK in ATM-/-, PARP-/-, and DNA-PKCS-deficient Scid cells was similar to that of wild-type BK4 cells (Figure 4A; and several other wild-type mouse fibroblast cell lines; unpublished data), indicating that early processing of DNA strand breaks is not involved in signaling to SAPK/JNK. However, 6 h after MMS exposure (designated as "late response"), Scid cells showed a clearly reduced phosphorylation of SAPK/JNK compared with ATM-/-, PARP-/-, and wild-type fibroblasts (Figure 4B). This was supported by a more detailed kinetic analysis (Figure 5A), revealing that MMS-induced phosphorylation of SAPK/JNK occurring within 1-2 h after exposure was similar in normal fibroblasts (BK4) and Scid cells, whereas at later times the phosphorylation level of SAPK/JNK further increased in wild-type cells but not in Scid (Figure 5A). A similar response was observed for the highly potent alkylating mutagen MNNG (Figure 5B). Compared with SAPK/JNK, the phosphorylation of p38 kinase upon MMS and MNNG treatment was only slightly affected in Scid cells (Figure 5, A and B). It should be noted that wild-type and Scid fibroblast responded similarly to SAPK/JNK phosphorylation upon UV-C treatment (Figure 5A), which points to the specificity of the observed stress response elicited by alkylating genotoxins. It is important to note that attenuation of late phosphorylation of SAPK/JNK in Scid cells was also detectable at the level of SEK1/MKK4 (Figure 5C). Yet, the MMS-induced increase in phosphorylation of checkpoint kinase 1 (Chk1) was even prolonged in Scid compared with wild-type cells (Figure 5C), showing that Scid cells are not generally impaired in DNA damage-triggered stress response. Overall, the data indicate that DNA-PKCS, which becomes activated by DNA strand breaks, is specifically required for alkylation-induced dual phosphorylation of SAPK/JNK by SEK1/MKK4.
|
|
CSB Is Essential for Late Phosphorylation of SAPK/JNK by MMS
Genotoxins also impair transcription. Therefore, we addressed the question of whether impaired transcription related repair processes upon MMS exposure might generate an additional signal to SAPK/JNK. To this end we studied cells that lack Cockayne syndrome group B protein (CSB-/- cells). The CSB protein is known to be a central player in the regulation of transcription-coupled repair of oxidative and UV-induced DNA damage (van der Horst et al., 1997
; van Gool et al., 1997
; Le Page et al., 2000
). As analyzed 4 h after exposure to different doses of MMS, SAPK/JNK phosphorylation was largely reduced in CSB-/- cells compared with normal mouse fibroblasts (BK4; Figure 6A) and CSB+/+ MEFs (Figure 6B, right panel). Phosphorylation of SEK1/MKK4 and p38 kinase was also reduced in CSB-deficient cells (Figure 6A). At early times (
2 h) after MMS exposure, phosphorylation of SAPK/JNK and p38 kinase was not impaired in CSB-/- cells (Figure 6B). Moreover, activation of SAPK/JNK was not impaired in CSB-/- cells upon their exposure to UV-C light, which was included as a control (Figure 6C). The data show that CSB protein is an essential component in late and sustained SEK1/MKK4-mediated phosphorylation of SAPK/JNK at Thr183/Tyr185 provoked by alkylating genotoxins.
|
Human DNA-PKcs- and CSB-defective Cells Also Do Not Show Late MMS-provoked Signaling to SAPK/JNK
To determine whether the data obtained with Scid- and CSB-deficient MEFs can be extended to human cells, DNA-PKcs- and CSB-defective human fibroblasts were investigated. As shown in Figure 7A, M050J glioblastoma cells, which lack DNA-PKcs activity (Virsik-Kopp et al., 2003
), revealed an impaired late phosphorylation of SAPK/JNK upon MMS exposure, compared with the corresponding wild-type cells (the line M059K; Figure 7A). Furthermore, late phosphorylation of SAPK/JNK and p38 kinase was also impaired in CSB-defective human cells compared with normal primary human fibroblasts, which were included as a control (Figure 7B) and responded similarly to MEFs. Thus, both mouse and human cells impaired in either DNA-PKcs or CSB display a defect in the late MMS-triggered phosphorylation of SAPK/JNK. Notably, the effect of DNA-PKcs and CSB on MMS-induced p38 kinase activation is different between the human and the mouse system. p53 is not involved in late signaling to SAPK/JNK upon MMS exposure because early and late activation of SAPK/JNK was very similar in p53 wild-type and p53 knock-out cells (unpublished data).
|
DNA-PKcs Interacts with SAPK/JNK
Having shown that DNA-PKcs and CSB are essential players in MMS-induced signaling from damaged DNA downstream to SAPK/JNK, the question arose as to the mechanism involved. To examine whether a direct interaction exists between the DNA repair proteins involved and SAPK/JNK, immunoprecipitation experiments were performed. They revealed that DNA-PKcs coprecipitates with both nonphosphorylated SAPK/JNK (JNK) and phosphorylated SAPK/JNK (p-JNK) as well as with p-SEK (Figure 8, A and B) and the mitogen-activated kinase phosphatase (MKP-1) (Figure 8B), which was described to act on stress kinases (Wu and Bennett, 2005
). No coprecipitation was observed if heat inactivated JNK antibody or antibody directed against p38 kinase was used (Figure 8A). MMS treatment did not increase the level of coprecipitated DNA-PKcs (Figure 8A). It is well established that DNA-PKcs interacts with Ku proteins (Ku70 and Ku86). Therefore, to corroborate the results of the immunoprecipitation experiments, we additionally checked for coprecipitation of Ku86 with SAPK/JNK. As shown in Figure 8, A and B, immunoprecipitation of JNK, p-JNK, p-SEK1, and MKP-1 also caused coprecipitation of Ku86 protein. Yet, coprecipitation was not observed for the nuclear mismatch repair protein MSH2 (Figure 8B), demonstrating the specificity of the observed interaction of DNA-PKcs and Ku-86. In contrast to BK4 cells, which harbor wild-type DNA-PKcs, Scid cells are mutated in their DNA-PKcs gene, therefore showing only very low residual amount of DNA-PKcs protein expression and activity (Blunt et al., 1996
; Beamish et al., 2000
). Correspondingly, the level of DNA-PKcs that coprecipitated with JNK from Scid cells was very low compared with wild-type BK4 cells (Figure 8C). SAPK/JNK not only binds to but also phosphorylates DNA-PKcs (Figure 8D). Most importantly, MMS treatment stimulates phosphorylation of DNA-PKcs by SAPK/JNK to a similar extent as that observed for c-Jun, which is the classical substrate for SAPK/JNK (Figure 8D). On the other hand, recombinant SAPK/JNK was neither substrate for phosphorylation by immunoprecipitated DNA-PKcs nor by commercially available purified DNA-PKcs protein (unpublished data).
|
Ras-homologous GTPases Are Essential for Early and Late Activation of SAPK/JNK by MMS
Early SEK1/MKK4-regulated dual phosphorylation of SAPK/JNK can result from activation of growth factor and cytokine receptors (Coffer et al., 1995
; Canman and Kastan, 1996
) and requires Ras-homologous (= Rho) GTPases (Coso et al., 1995
; Minden et al., 1995
). Therefore we were interested in elucidating whether Rho GTPases are also essential for MMS-induced late signaling to SAPK/JNK that originates from damaged DNA. Inhibition of Rho-dependent signaling by lovastatin, which blocks Rho by attenuating its C-terminal isoprenylation (Laufs and Liao, 1998
; Gnad et al., 2000
; von Bardeleben et al., 2003
), largely abrogated both the early and the late MMS-stimulated phosphorylation of SAPK/JNK as well as SEK1/MKK4 and, to a lesser extent, also p38 kinase (Figure 9A). Similar results were obtained using Toxin B (ToxB) from C. difficile (Figure 9A, right panel), which specifically inactivates Rho GTPases by glucosylation (Just et al., 1995
; Aktories et al., 2000
). Importantly, even if cells were treated with ToxB 1 h after MMS exposure, a strong attenuation of the late phosphorylation of SAPK/JNK was detected (Figure 9B). The same holds true for phosphorylation of SEK1/MKK4 (Figure 9B). From this we conclude that Rho is essential for MMS-induced late SEK1/MKK4-catalyzed phosphorylation of SAPK/JNK. This implicates a cross-talk of Rho GTPases with signal mechanisms originating from damaged DNA.
|
MMS-induced DNA-PKcs- and CSB-regulated Late Signaling to SAPK/JNK Is Independent of MKP-1
It might be argued that reduced late phosphorylation of SAPK/JNK in DNA-PKcs- and CSB-defective cells is due to protein kinase phosphatases such as MKP-1 (Wu and Bennett, 2005
). As shown in Figure 10, MKP-1 protein expression increased in wild-type, Scid and CSB-/- cells upon MMS treatment, with wild-type cells showing the strongest response. MMS-induced expression of MKP-1 was completely abrogated in all cell lines by Ro-318220 (Figure 10A), a protein kinase C inhibitor that is reported to impair MPK-1 phosphatase expression (Guo et al., 1998
). Ro-318220 does not affect MMS-induced activation of SAPK/JNK, neither in wild-type nor in repair-defective cells (Figure 10B). That Ro-318220 was functioning in these experiments has been scrutinized by parallel analysis of MKP-1 expression using the same extracts (unpublished data). Thus, we conclude that MKP-1-related mechanisms are not relevant for the reduction of late MMS-driven SAPK/JNK phosphorylation observed in DNA-PKcs- and CSB-defective cells.
|
| DISCUSSION |
|---|
|
|
|---|
B (Bender et al., 1998
Because the main cellular target of MMS is the DNA, specific nonrepaired DNA methylation lesions or repair intermediates were initially considered as candidates responsible for the initiation of the signal cascade resulting in SAPK/JNK phosphorylation. Because most of the methylation lesions are repaired by BER (Christmann et al., 2003
), we examined whether modulation of this repair pathway influences activation of SAPK/JNK by MMS. N-methylpurines are removed by MPG. Yet, MPG knockout MEFs did not differ from the corresponding wild-type cells as to MMS-induced phosphorylation of SAPK/JNK. Furthermore, chemical inhibitors of BER were also ineffective in changing the response. Obviously, DNA methylation lesions themselves, even if they remain unrepaired, do not trigger signaling to SAPK/JNK. Also DNA DSBs, which can be induced by MMS (presumably due to labilization of phosphate backbone by methyl phosphotriesters), are very likely not responsible for triggering Thr183/Tyr185 phosphorylation of SAPK/JNK because IR, a well-known inducer of DSB, is a rather poor activator of dual phosphorylation of SAPK/JNK (shown here and by others; Lee et al., 1998
). Nevertheless, IR triggers a JNK-mediated phosphorylation of c-Jun as measured by the complex kinase assay method (Lee et al., 1998
). Apparently stimulation of SAPK/JNK activity by IR is independent of Thr183/Tyr185 phosphorylation of the kinase. Alkylating agents need DNA replication in order to provoke genotoxic effects (Kaina, 2003
). Therefore, we hypothesized some other DNA damage-related lesions formed during DNA replication to be involved. Inhibition of DNA replication itself or inhibition of transcription should also be taken into consideration. Comparing MMS-induced SAPK/JNK phosphorylation in growing versus nongrowing cells, we found phosphorylation to be reduced by
50% in nonreplicating cells. This indicates that replication-mediated lesions, or the block of DNA replication itself, is involved in signaling SAPK/JNK activation. This is in line with the time kinetic and dose-response analyses that showed a correlation between both end points. Inhibition of DNA replication by the DNA polymerase inhibitors aphidicolin and hydroxyurea (unpublished data) also caused SAPK/JNK phosphorylation, supporting the view that replication blockage is critical in signaling to SAPK/JNK. MMS largely potentiated aphidicolin-induced signaling to SAPK/JNK, whereas p38 kinase phosphorylation was only slightly promoted by combination treatment. Apparently, MMS-induced signal mechanisms eventually resulting in activation of SAPK/JNK and p38 kinase are different. Based on the data, it is pertinent to conclude that, in addition to replication-related processes, alkylation specific mechanisms such as collapse of replication forks and the generation of secondary lesions, presumably transient DNA breaks of specific structure, contribute to the signaling to SAPK/JNK.
Replication-dependent formed DNA lesions may be recognized by sensor molecules. A key player might be proteins that recognize and bind to DNA breaks that appear as repair and replication intermediates. Therefore, we investigated whether lack of sensors of DNA strand breaks such as ATM and DNA-PKCS, which become activated by DSBs and are the most important players in DNA damage-triggered signaling, checkpoint control, and repair (Liu et al., 2000
; Zhou and Elledge, 2000
; Cortez et al., 2001
; Durocher and Jackson, 2001
), or PARP have impact on SAPK/JNK phosphorylation by MMS. We found that DNA-PKCS-mutated cells (Scid), but not ATM-/- and PARP-/- fibroblasts, exhibited significantly reduced SAPK/JNK phosphorylation, which was observed
4 h after MMS exposure. At early times (
2 h) after MMS treatment Scid cells did not differ from the wild type. Because the time course of UV-C-stimulated SAPK/JNK phosphorylation was similar in wild-type and Scid cells, we conclude that DNA-PKCS is specifically required for the late MMS response giving rise to SAPK/JNK phosphorylation. Abrogation of the late SAPK/JNK phosphorylation in DNA-PKCS-deficient cells was also observed when another alkylating agent, the potent mutagen MNNG, was used for treatment. The effect is not restricted to MEFs. Comparing DNA-PKCS-proficient and -deficient human glioblastoma cells, essentially identical results were obtained. Overall, our findings indicate that alkylating genotoxins provoke late SEK1/MKK4-dependent signaling to SAPK/JNK, which requires DNA-PKCS. Because MMS-induced signaling to Chk1 was not attenuated (it was rather enhanced) in DNA-PKCS-deficient cells, DNA-PKCS appears to be required for signaling to SAPK/JNK but not to checkpoint kinases. Bearing in mind that genotoxin-induced activation of SAPK/JNK has been shown to increase the repair of DNA adducts (Potapova et al., 1997
; Hayakawa et al., 2003
, 2004
), it is tempting to speculate that DNA-PKcs-defective cells, which lack a putatively protective activation of SAPK/JNK, show a MMS-hypersensitive phenotype. Initial experiments indicate that this is indeed the case (unpublished data). Therefore, we suggest that late DNA-PKcs-dependent activation of SAPK/JNK contributes to a MMS-resistant phenotype.
As MMS may also impair transcription and transcription-related processes such as transcription-coupled repair (TCR), we investigated whether absence of CSB, which is known to be a central player in TCR (van Gool et al., 1997
), impacts on the phosphorylation level of SAPK/JNK. Similar to the findings with DNA-PKCS-defective cells, lack of CSB dramatically impaired late phosphorylation of SAPK/JNK. The early phosphorylation step remained unaffected. Again, similar to Scid cells, the effect was alkylation specific. It was not observed for UV-C that triggered activation of SAPK/JNK in wild-type and CSB-/- fibroblasts to a similar extent. Identical results were obtained with human CSB-deficient fibroblasts. The data show that CSB is required for MMS-induced late signaling giving rise to SAPK/JNK phosphorylation. Because CSB-defective cells reveal a MMS-hypersensitive phenotype (unpublished data), we assume that late SAPK/JNK activation upon MMS exposure has a protective function. It is worthwhile to note that p53-/- cells do not differ from p53 wild-type cells as to the phosphorylation of SAPK/JNK after MMS treatment, showing that this DNA damage response is independent of p53 (unpublished data).
The kinase function of DNA-PKcs is known to be activated upon binding of the protein to DNA double-strand breaks. Therefore, we asked whether activated DNA-PKcs directly phosphorylates SAPK/JNK. For direct phosphorylation a physical contact would be postulated. To substantiate a physical interaction of DNA-PKcs with stress kinase, immunoprecipitation experiments and in vitro kinase assays were performed. The immunoprecipitation experiments showed a specific coprecipitation of DNA-PKcs and Ku-86 with SAPK/JNK, SEK1/MKK4, and MKP-1. Yet, DNA-PKcs was not found to phosphorylate recombinant SAPK/JNK in vitro. However, SAPK/JNK was able to phosphorylate DNA-PKcs in vitro. This reaction was stimulated by MMS to a similar extent as phosphorylation of c-Jun, which is the classical substrate of SAPK/JNK. Overall, the data show for the first time that there is a physical interaction between stress kinases (i.e., SEK1/MKK4 and SAPK/JNK) and DNA-PKcs, which supports the view that DNA-PKcs is a key player in DNA damage-induced cellular responses. DNA-PKcs and CSB may be considered as DNA damage sensors that deliver signaling downstream to AP-1-governed gene expression. The mechanism appears to be complex because signaling also requires Rho GTPases as an essential component for late phosphorylation of SEK1/MKK4 and SAPK/JNK. Whether there is a DNA damage-triggered de novo activation of individual Rho proteins or whether Rho GTPases have a permissive function for DNA damage-triggered signaling to SAPK/JNK is still unclear and will be subject of forthcoming studies. Because the tyrosine kinase c-Abl is reported to become activated in a DNA damage-dependent manner (Kharbanda et al., 1995
; Yoshida et al., 2005
), it appears feasible that c-Abl is also involved in the MMS-triggered signaling cascade, which requires DNA-PKcs and CSB and eventually leads to the activation of SAPK/JNK.
|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| Footnotes |
|---|
Address correspondence to: Gerhard Fritz (fritz{at}mail.uni-mainz.de).
| REFERENCES |
|---|
|
|
|---|
Arlt, A., Vorndamm, J., Breitenbroich, M., Folsch, U. R., Kalthoff, H., Schmidt, W. E., and Schafer, H. ((2001). ). Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20, , 859-868.[CrossRef][Medline]
Beamish, H. J., Jessberger, R., Riballo, E., Priestley, A., Blunt, T., Kysela, B., and Jeggo, P. A. ((2000). ). The C-terminal conserved domain of DNA-PKcs, missing in the SCID mouse, is required for kinase activity. Nucleic Acids Res. 28, , 1506-1513.
Bender, K., Göttlicher, M., Whiteside, S., Rahmsdorf, H. J., and Herrlich, P. ((1998). ). Sequential DNA damage-independent and -dependent activation of NF-kB by UV. EMBO J. 17, , 5170-5181.[CrossRef][Medline]
Blunt, T., Gell, D., Fox, M., Taccioli, G. E., Lehmann, A. R., Jackson, S. P., and Jeggo, P. A. ((1996). ). Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc. Natl. Acad. Sci. USA 93, , 10285-10290.
Brozovic, A., Fritz, G., Christmann, M., Zisowsky, J., Jaehde, U., Osmak, M., and Kaina, B. ((2004). ). Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int. J. Cancer 112, , 974-985.[CrossRef][Medline]
Canman, C. E., and Kastan, M. B. ((1996). ). Three paths to stress relief. Nature 384, , 213-214.[CrossRef][Medline]
Christmann, M., Tomicic, M. T., Roos, W. P., and Kaina, B. ((2003). ). Mechanisms of human DNA repair: an update. Toxicology 193, , 3-34.[CrossRef][Medline]
Coffer, P. J., Burgering, B. M., Peppelenbosch, M. P., Bos, J. L., and Kruijer, W. ((1995). ). UV activation of receptor tyrosine kinase activity. Oncogene 11, , 561-569.[Medline]
Cortez, D., Guntuku, S., Qin, J., and Elledge, S. J. ((2001). ). ATR and ATRIP: partners in checkpoint signaling. Science 294, , 1713-1716.
Coso, A. A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. ((1995). ). The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81, , 1137-1146.[CrossRef][Medline]
Deng, X., Xiao, L., Lang, W., Gao, F., Ruvolo, P., and May, W. S., Jr. ((2001). ). Novel role for JNK as a stress-activated Bcl2 kinase. J. Biol. Chem. 276, , 23681-23688.
Devary, Y., Rosette, C., DiDonato, J. A., and Karin, M. ((1993). ). NFkappaB activation by ultraviolet light not dependent on a nuclear signal. Science 261, , 1442-1445.
Dosch, J., and Kaina, B. ((1996). ). Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Oncogene 13, , 1927-1935.[Medline]
Durocher, D., and Jackson, S. P. ((2001). ). DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 13, , 225-231.[CrossRef][Medline]
Gjerset, R. A., Lebedeva, S., Haghighi, A., Turla, S. T., and Mercola, D. ((1999). ). Inhibition of the Jun kinase pathway blocks DNA repair, enhances p53-mediated apoptosis and promotes gene amplification. Cell Growth Differ. 10, , 545-554.
Gnad, R., Aktories, K., Kaina, B., and Fritz, G. ((2000). ). Inhibition of protein isoprenylation impairs Rho-regulated early cellular response to genotoxic stress. Mol. Pharmacol. 58, , 1389-1397.[Medline]
Gross, S., Knebel, A., Tenev, T., Neininger, A., Gaestel, M., Herrlich, P., and Bohmer, F. D. ((1999). ). Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J. Biol. Chem. 274, , 26378-26386.
Guo, Y. L., Kang, B., and Williamson, J. R. ((1998). ). Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273, , 10362-10366.
Haas, S., and Kaina, B. ((1995). ). c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis 16, , 985-991.
Hayakawa, J., Depatie, C., Ohmichi, M., and Mercola, D. ((2003). ). The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J. Biol. Chem. 278, , 20582-20592.
Hayakawa, J., Mittal, S., Wang, Y., Korkmaz, K. S., Adamson, E., English, C., Ohmichi, M., McClelland, M., and Mercola, D. ((2004). ). Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol. Cell 16, , 521-535.[CrossRef][Medline]
Herr, I., Wilhelm, D., Bohler, T., Angel, P., and Debatin, K. M. ((1997). ). Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, , 6200-6208.[CrossRef][Medline]
Huang, C., Ma, W., Bowden, G. T., and Dong, Z. ((1996a). ). Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKClambda/iota. J. Biol. Chem. 271, , 31262-31268.
Huang, R. P., Wu, J. X., Fan, Y., and Adamson, E. D. ((1996b). ). UV activates growth factor receptors via reactive oxygen intermediates. J. Cell. Biol. 133, , 211-220.
Ichijo, H. ((1999). ). From receptors to stress-activated MAP kinases. Oncogene 18, , 6087-6093.[CrossRef][Medline]
Just, I., Selzer, J., Wilm, M., Von Eichel-Streiber, C., Mann, M., and Aktories, K. ((1995). ). Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, , 500-503.[CrossRef][Medline]
Kaina, B. ((2003). ). DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem. Pharmacol. 66, , 1547-1554.[CrossRef][Medline]
Kaina, B., Haas, S., and Kappes, H. ((1997). ). A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res. 57, , 2721-2731.
Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. ((1995). ). Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376, , 785-788.[CrossRef][Medline]
Kitagawa, D. et al. ((2002). ). Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J. Biol. Chem. 277, , 366-371.
Knebel, A., Rahmsdorf, H. J., Ullrich, A., and Herrlich, P. ((1996). ). Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15, , 5314-5325.[Medline]
Kolbus, A., Herr, I., Schreiber, M., Debatin, K. M., Wagner, E. F., and Angel, P. ((2000). ). c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20, , 575-582.
Lackinger, D., and Kaina, B. ((2000). ). Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. Mutat. Res. 457, , 113-123.[Medline]
Laufs, U., and Liao, J. K. ((1998). ). Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273, , 24266-24271.
Le Page, F., Kwoh, E. E., Avrutskaya, A., Gentil, A., Leadon, S. A., Sarasin, A., and Cooper, P. K. ((2000). ). Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell 101, , 159-171.[CrossRef][Medline]
Lee, S. A., Dritschilo, A., and Jung, M. ((1998). ). Impaired ionizing radiation-induced activation of a nuclear signal essential for phosphorylation of c-Jun by dually phosphorylated c-Jun amino-terminal kinases in ataxia telangiectasia fibroblasts. J. Biol. Chem. 273, , 32889-32894.
Li, N., and Karin, M. ((1998). ). Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95, , 13012-13017.
Liu, Q. et al. ((2000). ). Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14, , 1448-1459.
Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., and Claret, F. X. ((2003). ). Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J. Biol. Chem. 278, , 19245-19256.
Maundrell, K. et al. ((1997). ). Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272, , 25238-25242.
Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. ((1995). ). Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81, , 1147-1157.[CrossRef][Medline]
Nehme, A., Baskaran, R., Aebi, S., Fink, D., Nebel, S., Cenni, B., Wang, J. Y., Howell, S. B., and Christen, R. D. ((1997). ). Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 57, , 3253-3257.
Nehme, A., Baskaran, R., Nebel, S., Fink, D., Howell, S. B., Wang, J. Y., and Christen, R. D. ((1999). ). Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br. J. Cancer 79, , 1104-1110.[CrossRef][Medline]
Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., and Mercola, D. ((1997). ). The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272, , 14041-14044.